NEW YORK, March 22, 2018 /PRNewswire/ -- Oppenheimer
& Co. Inc. ("Oppenheimer"), a unit of Oppenheimer Holdings
(NYSE: OPY), recently hosted its 28th Annual Healthcare
Conference in New York City on
March 20 and 21, 2018. The two-day
conference brought together leading public and private companies
across major sectors of the healthcare industry, including
Novartis, Nektar, Vertex, Seattle Genetics, Medtronic, Centene,
Cigna, and Humana. Dr. Gillian
Woollett with Avalere offered the keynote presentation on
Tuesday while Marwood Group offered the keynote Wednesday.
Through company presentations, 1on1 and group meetings, and
panel lectures, the event provided investors with insights on
important issues such as health reform implementation, Medicare and
Medicaid policy changes, drug regulation, and new pharmaceutical
and biotechnology products. In total, there were seven panels, with
two focused on financing and five focused on emerging healthcare
issues and trends, including the opioid crisis and precision
medicine, alternative public offerings, next steps on cancer cell
therapy, and the evolving CAR-T therapy landscape.
The conference featured Oppenheimer's Senior Research Analysts
who offered guidance on many aspects of the healthcare sector,
including the following:
- Derek Archila, Executive
Director and Senior Analyst covering Bio & Specialty
Pharmaceuticals
- Mark Breidenbach, PH. D.,
Executive Director and Senior Analyst covering Biotechnology
- Leah Cann, Managing Director and
Senior Analyst covering Biotechnology
- Leland Gershell, Managing
Director and Senior Analyst covering BioPharmaceuticals
- Steven Lichtman, Managing
Director and Senior Analyst covering Medical Devices
- Mohan Naidu, Managing Director
and Senior Analyst covering the Healthcare Information Technology
(HCIT) sector
- Jay Olson, Executive Director
and Senior Analyst covering Biotechnology
- Hartaj Singh, Managing Director and Senior Analyst covering
Biotechnology
- Michael Wiederhorn, Managing
Director and Senior Analyst covering Healthcare Providers and
Services
"Oppenheimer's conference is strategically designed to help
investors better understand the complex dynamics of today's
healthcare industry," said Erica L.
Moffett, Managing Director and Head of Research Marketing
Services. "With new advancements in technology revolutionizing the
healthcare and pharmaceutical business, our clients, now more than
ever, rely on our expertise to help them better understand the
industry. The conference agenda promotes education and learning so
investors leave with key insights to help their portfolios."
The event was sponsored by a number of leading Firms including
Equisolve, Lowenstein Sandler LLP, Mintz, Levin, Cohn, Glovsky
& Popeo P.C., Sullivan & Worcester LLP, Ellenoff Grossman
& Schole LLP, FactSet Research Systems Inc., M2 Compliance,
Marcum LLP, Mayer Hoffman McCann, Sichenzia Ross Ference Kesner
LLP, and Toppan Vintage.
Oppenheimer's next conference will be the 13th Annual Industrial
Growth Conference, which will be held May
8-9, 2018 in New York City.
Also held in New York is the
3rd Annual Emerging Growth Conference on May 15, 2018.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary
of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange),
and its affiliates provide a full range of wealth management,
securities brokerage and investment banking services to
high-net-worth individuals, families, corporate executives, local
governments, businesses and institutions.
View original
content:http://www.prnewswire.com/news-releases/oppenheimer--co-inc-concludes-its-twenty-eighth-annual-healthcare-conference-in-new-york-city-300618180.html
SOURCE Oppenheimer & Co. Inc.